Literature DB >> 15728446

Continuous cultures of fused cells secreting antibody of predefined specificity. 1975.

G Köhler, C Milstein.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15728446

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  42 in total

1.  Production of monoclonal antibodies against serum immunoglobulins of black rockfish (Sebastes schlegeli Higendorf).

Authors:  Geewook Shin; Hyungjun Lee; K J Palaksha; Youngrim Kim; Eunyoung Lee; Yongseung Shin; Eunggoo Lee; Kyungdae Park; Taesung Jung
Journal:  J Vet Sci       Date:  2006-09       Impact factor: 1.672

2.  Tumour inflammatory response: adding fuel to the fire?

Authors:  M Valdes; M R Chasen
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

3.  New model for cardiomyocyte sheet transplantation using a virus-cell fusion technique.

Authors:  Yuto Takahashi; Daihachiro Tomotsune; Sakiko Takizawa; Fengming Yue; Mika Nagai; Tadayuki Yokoyama; Kanji Hirashima; Katsunori Sasaki
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

4.  Construction of human ScFv phage display library against ovarian tumor.

Authors:  Jinsong Xia; Hao Bi; Qin Yao; Shen Qu; Yiqiang Zong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  A Bioassay for Optimization of Macrophage-Conditioned Medium as a Culture Supplement to Promote Hybridoma Cell Survival and Growth.

Authors:  Robert Hnasko; Alice V Lin; Larry Stanker; Jeffery McGarvey
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2018-06-14

6.  Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas.

Authors:  Paul W Price; Elizabeth C McKinney; Youliang Wang; Loren E Sasser; Muthugapatti K Kandasamy; Linda Matsuuchi; Christine Milcarek; Roger B Deal; Deborah G Culver; Richard B Meagher
Journal:  J Immunol Methods       Date:  2009-01-31       Impact factor: 2.303

Review 7.  CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas.

Authors:  Alexandra S Onea; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

8.  Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study.

Authors:  Lee S Schwartzberg; Edward J Stepanski; Mark S Walker; Susan Mathias; Arthur C Houts; Barry V Fortner
Journal:  Support Care Cancer       Date:  2008-07-01       Impact factor: 3.603

9.  Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.

Authors:  Xiaoxian Zhao; Shweta Singh; Cecile Pardoux; Jingsong Zhao; Eric D Hsi; Arie Abo; Wouter Korver
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

Review 10.  An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.

Authors:  Patrick C Gedeon; Bryan D Choi; Tiffany R Hodges; Duane A Mitchell; Darell D Bigner; John H Sampson
Journal:  Expert Rev Clin Pharmacol       Date:  2013-07       Impact factor: 5.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.